A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Southern California
Icahn School of Medicine at Mount Sinai
Center for International Blood and Marrow Transplant Research
University of Washington
City of Hope Medical Center
Fred Hutchinson Cancer Center
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Ryvu Therapeutics SA
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Incyte Corporation
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Italfarmaco
Fred Hutchinson Cancer Center
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Ottawa Hospital Research Institute
GlaxoSmithKline
Telios Pharma, Inc.
Incyte Corporation
Keros Therapeutics, Inc.
M.D. Anderson Cancer Center
University of Birmingham
Celgene
Sierra Oncology LLC - a GSK company
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Alabama at Birmingham
Stichting Hemato-Oncologie voor Volwassenen Nederland
Incyte Corporation